FDA
approval
· 2018-10-19
FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
The FDA approved a supplemental application for vortioxetine (Trintellix) submitted by Takeda Pharmaceuticals America. The approval updates the product labeling…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRINTELLIX (VORTIOXETINE)